Skip to search formSkip to main contentSkip to account menu

Eplivanserin

Known as: 4-[(1E,3Z)-3-{[2-(dimethylamino)ethoxy]imino}-3-(2-fluorophenyl)prop-1-enyl]phenol, SR46349 
National Institutes of Health

Related topics

Related topics

1 relation
Eplivanserin Hemifumarate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The Involvement of 5-HT 2A Receptor in the Regulation of Sleep and Wakefulness, and the Potential Therapeutic Use of Selective 5-HT 2A Receptor Antagonists and Inverse Agonists for the Treatment of…
Several agents have been shown to improve sleep induction and/or maintenance in patients with primary or comorbid insomnia. These… 
Review
2010
Review
2010
[The newer sedative-hypnotics].
There has been a search for more effective and safe hypnotic drugs in the last decades. Zolpidem, zaleplon, zopiclone… 
2010
2010
Eplivanserin Beats Flurazepam On Next-Day Cognitive Effects
Review
2009
Review
2009
FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b…
Recent FDA action (through November 2009) related to Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR… 
2009
2009
Verfahren zur Behandlung von Schlafstörungen mit Eplivanserin
2009
2009
Verfahren zur herstellung von eplivanserin hemifumarat
Highly Cited
2008
Highly Cited
2008
5-HT(2A) inverse-agonists for the treatment of insomnia.
Nearly one half of the adult population in the U.S. experience some symptoms of insomnia (difficulties with getting to sleep… 
2008
2008
Eplivanserin Soothes Insomnia Without Next-Morning Effects
2004
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
1996
1996
Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)